|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6827 | (2018.01) |
| C12Q 1/6827 | (2013.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3283627 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16780809.6 |
| Date of filing the European patent application | 2016-04-15 | |
| (97) | Date of publication of the European application | 2018-02-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/027696 |
| Date | 2016-04-15 |
| (87) | Number | WO 2016/168561 |
| Date | 2016-10-20 |
| (30) | Number | Date | Country code |
| 201562147851 P | 2015-04-15 | US | |
| 201562248154 P | 2015-10-29 | US |
| (72) |
SUNDARESAN, Tilak K. , US
ZHENG, Zongli , CN
HABER, Daniel A. , US
MAHESWARAN, Shyamala , US
IAFRATE, A. John , US
|
| (73) |
The General Hospital Corporation ,
55 Fruit Street, Boston, MA 02114,
US
|
| (54) | LNA-BASED MUTANT ENRICHMENT NEXT-GENERATION SEQUENCING ASSAYS |
| LNA-BASED MUTANT ENRICHMENT NEXT-GENERATION SEQUENCING ASSAYS |